Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Amgen .
Filed returns
20
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Amgen | EU Affairs | Participation in a multi stakeholder life sciences roundtable on EU and Irish policy issues affecting the sector's competitiveness (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2026 | Amgen | EU Affairs | Correspondence on the proposed EU Biotech Act, including Amgen's proposed amendments (Legislation) | 3 | On lobbying.ie |
| May–Aug 2026 | Amgen | Health | Meeting and briefing on cardiovascular prevention policy and the case for a new national cardiovascular strategy (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2026 | Amgen | Economic Development and Industry | Manufacturing site visit and discussion of policy issues relevant to the life sciences sector and Ireland's industrial competitiveness (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2026 | Amgen | Health | Engagement with MEP Kelleher on EU legislations (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Amgen | Health | Thank you letter to the Minister for Health for collaboration on the IPHA Agreement (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Amgen | Health | Requested a meeting with MEP Kelleher to introduce Amgen and discuss EU General Pharma Legislation, Critical Medicines Act, and the upcoming Biotech Act (Legislation) | 1 | On lobbying.ie |
| May–Aug 2025 | Amgen | Health | Discussion of Critical Medicines Act and other biopharma industry topics (Legislation) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Amgen | Health | Meeting with MEP Cynthia NÍ MHURCHÚ on EU legislation such as the Critical Medicines Act and upcoming Biotech Act (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Amgen | Health | Email requesting a meeting with MEP Billy Kelleher to discuss EU legislation such as the Critical Medicines Act and upcoming Biotech Act (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Amgen | Trade | Conversation on trade policy and the impact on the pharmaceuticals sector (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Discussed regulation, need to keep EU competitive and support more clinical trials in Europe as part of AmCham EU delgation (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Requested meetings to discuss need to prioritize EU health policy and enhance EU competitiveness in biotech and life sciences in Ireland (Legislation) | 5 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Discussed EU competitiveness for biopharmaceutical industry investments at ALDE 2024 party conference roundtable; discussed Biotech Act, EU Pharma Legislation, and Draghi Report. (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Highlight importance of EU Biotech Act and finalization/implementation of EU Pharma Legislation, European Health Data Space, In Vitro Diagnostic Regulation and Clinical Trials Act as part of EU competitiveness. (Legislation) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Discussed Amgen's current and future investments in Ireland; discussed EU Pharma Legislation. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Discussed EU pharmaceutical legislation, IP, market access to innovative medicines, and Amgen's manufacturing footprint in Ireland (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Discussed EU pharmaceutical legislation, market access to innovative medicines, and Amgen's manufacturing footprint in Ireland (Legislation) | 1 | On lobbying.ie |
| May–Aug 2024 | Amgen | Health | Invitation for Taoiseach to attend Amgen Biotech Experience (ABE) event and meeting (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2024 | Amgen | Health | Request for meeting with Minister Burke regarding life sciences policy (Public policy or programme) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 16 | 80.0% | |
| EU Affairs | 2 | 10.0% | |
| Economic Development and Industry | 1 | 5.0% | |
| Trade | 1 | 5.0% |